HappeningToo topic
Upadacitinib reports
Browse community reports connected to Upadacitinib. These reports can show that other people are describing similar experiences, but they do not prove that Upadacitinib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
28 problems
Abdominal Discomfort while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and abdominal discomfort appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and abdominal pain upper appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and abdominal pain appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acne while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and acne appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and alopecia appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and back pain appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and constipation appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and cough appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and decreased appetite appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and diarrhea appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and dizziness appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and fatigue appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and feeling abnormal appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and headache appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and insomnia appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and itching appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and malaise appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and muscle spasms appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and nausea appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and pain appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and rash appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and shortness of breath appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and skin redness appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and swelling appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and vomiting appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and weakness appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and weight decreased appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Upadacitinib
FDA FAERS contains adverse-event reports in which Upadacitinib and weight increased appear together. This does not establish that Upadacitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →